Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Receivables (2024 - 2025)

Profound Medical (PROF) has 2 years of Change in Receivables data on record, last reported at -$736000.0 in Q4 2025.

  • For Q4 2025, Change in Receivables fell 223.7% year-over-year to -$736000.0; the TTM value through Dec 2025 reached $172000.0, up 192.47%, while the annual FY2025 figure was $172000.0, 192.47% up from the prior year.
  • Change in Receivables reached -$736000.0 in Q4 2025 per PROF's latest filing, down from $3.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $3.4 million in Q3 2025 and bottomed at -$1.4 million in Q2 2025.